Upload
Featured Recent Articles Topics Login Upload

Search Results for ''

published presentations and documents on DocSlides.

Management of Cirrhosis for the Primary Care Provider
Management of Cirrhosis for the Primary Care Provider
by norah
Nicholas Lim, MD. Associate Professor of Medicine....
HBV related cirrhosis Geoff Dusheiko
HBV related cirrhosis Geoff Dusheiko
by maxasp
Kings College Hospital London UK. . 20–50%. . ...
Decompensated cirrhosis Clinical Practice Guidelines
Decompensated cirrhosis Clinical Practice Guidelines
by kittie-lecroy
About these slides. These slides give a comprehen...
Cirrhosis and complications
Cirrhosis and complications
by conchita-marotz
Best of ILC 2018. About these slides. These slide...
MM: HCV and Cirrhosis Patient Case
MM: HCV and Cirrhosis Patient Case
by devin732
Chris Kolkman. PrimaryOne. Health. Meet MM. Patie...
Management of cirrhosis Dr
Management of cirrhosis Dr
by eliza
Nowlan Selvapatt. Consultant Hepatologist. Imperia...
Abstract Patients with advanced liver disease have traditionally been considered at risk for bleedi
Abstract Patients with advanced liver disease have traditionally been considered at risk for bleedi
by friendma
portal hypertension, . research performed within t...
Susana G. Rodrigues, MD-PhD student; Apr ‘17-Jul ’19, funded by the
Susana G. Rodrigues, MD-PhD student; Apr ‘17-Jul ’19, funded by the
by dudeja
Stiftung. . für. . Leberkrankheiten. . Bern. 1...
Hepatocellular Carcinoma in the Absence of Cirrhosis
Hepatocellular Carcinoma in the Absence of Cirrhosis
by olivia-moreira
Richa Shukla. Faculty mentor: Dr. Sahil Mittal. F...
Common Misconceptions in
Common Misconceptions in
by mitsue-stanley
Liver Disease and Cirrhosis. Justin Mitchell, DO,...
Terry D. Box, MD Associate Professor of Medicine
Terry D. Box, MD Associate Professor of Medicine
by liane-varnes
Terry D. Box, MD Associate Professor of Medicine ...
Mazen Hassanain Portal Hypertension
Mazen Hassanain Portal Hypertension
by escapistlego
Causes. Cirrhosis. Non-cirrhosis. Symptoms. Asympt...
Hepatocellular Carcinoma in the Absence of Cirrhosis
Hepatocellular Carcinoma in the Absence of Cirrhosis
by pinperc
Richa Shukla. Faculty mentor: Dr. Sahil Mittal. Fe...
COMPLICATIONS OF LIVER CIRRHOSIS
COMPLICATIONS OF LIVER CIRRHOSIS
by elyana
DR. SANJANA BHAGWAT. MODERATOR : DR. SHIMPA SHARMA...
archiv euromedica 31303130 29ol 2830 num
archiv euromedica 31303130 29ol 2830 num
by wilson
| archiv euromedica  ol...
EFFICACY AND SAFETY OF THE INTERFERON-FREE COMBINATION OF
EFFICACY AND SAFETY OF THE INTERFERON-FREE COMBINATION OF
by hezekiah
FALDAPREVIR (BI 201335) + BI 207127 ± RIBAVIRIN. ...
Alcoholic Liver Disease Directed Readings
Alcoholic Liver Disease Directed Readings
by min-jolicoeur
In the Classroom. July/August 2013 issue of . Rad...
Cirrhosis and complications Best of ILC 2018 About
Cirrhosis and complications Best of ILC 2018 About
by alexa-scheidler
Cirrhosis and complications Best of ILC 2018 About...
Terry D. Box, MD
Terry D. Box, MD
by ellena-manuel
Associate Professor of Medicine. Division of . Ga...
Alcoholic Liver Disease
Alcoholic Liver Disease
by stefany-barnette
Directed Readings . In the Classroom. July/August...
Terry D. Box, MD
Terry D. Box, MD
by alexa-scheidler
Associate Professor of Medicine. Division of . Ga...
No randomisation
No randomisation
by tatiana-dople
N = 100. W12. W24. Arm B: . compensated cirrhosis...
CRONIC HEPATITIS, CIRRHOSIS, HEPATIC FAILURE
CRONIC HEPATITIS, CIRRHOSIS, HEPATIC FAILURE
by tawny-fly
ASSOC. PROF. DR. INGRID MIRON. What is Viral Hepa...
Dr. Ravi kant Assistant Professor Department of General Medicine
Dr. Ravi kant Assistant Professor Department of General Medicine
by briana-ranney
Dr. Ravi kant Assistant Professor Department o...
Liver dysfunction and Drugs metabolism Dr V.Sebghatollahi
Liver dysfunction and Drugs metabolism Dr V.Sebghatollahi
by lois-ondreau
Liver dysfunction and Drugs metabolism Dr V.Se...
Efficacy and Safety of
Efficacy and Safety of
by olivia-moreira
Efficacy and Safety of Glecaprevir / Pibrentasvi...
PRIMARY BILIARY CIRRHOSIS
PRIMARY BILIARY CIRRHOSIS
by faith
PRESENTED BY : . Hawa-A-Elbarghthi. Marwa-A- . Elf...
Translational Liver Consortia:
Translational Liver Consortia:
by susan2
TLC and THCCC. Hashem B. El-Serag, MD, MPH. Chair ...
Andrew J. Muir, MD, MHS Chief, Division of Gastroenterology
Andrew J. Muir, MD, MHS Chief, Division of Gastroenterology
by badra
Duke University School of Medicine. Durham, North ...
Hepatitis C Imtiaz Alam, M.D.
Hepatitis C Imtiaz Alam, M.D.
by olivia-moreira
Medical Director, Austin Hepatitis Center. 1. Hep...
PERIOPERATIVE MANAGEMENT OF THE PATIENTS WITH LIVER DISEA
PERIOPERATIVE MANAGEMENT OF THE PATIENTS WITH LIVER DISEA
by jasmine
SE . . . Dr - MOHAMMED EMAM. PROF. GASTRENTROLOGY ...
Journal Club - 25.04.19 ß blockers to prevent decompensation of cirrhosis in patients with clinica
Journal Club - 25.04.19 ß blockers to prevent decompensation of cirrhosis in patients with clinica
by everly
PREDESCI. ): a randomised, double-blind, placebo-c...
787Pentraxin-3 (PTX3) in cirrhotic patients.
787Pentraxin-3 (PTX3) in cirrhotic patients.
by finley
2017; 16 (5): 780-787 j.micinf.2005.12.017].30.Dia...
Daclatasvir Plus Sofosbuvir With or Without Ribavirin in Patients With HCV Genotype 3 Infection:
Daclatasvir Plus Sofosbuvir With or Without Ribavirin in Patients With HCV Genotype 3 Infection:
by kittie-lecroy
Interim Analysis of a French Multicenter Compassi...
HCV Screening and Linkage to Care
HCV Screening and Linkage to Care
by alexa-scheidler
Program in a Pharmacy Setting. Conveying . the Ur...
Charles Landis, MD, PhD
Charles Landis, MD, PhD
by tawny-fly
Assistant . Professor of Medicine. Division of Ga...
Taking Steps to Improve the Management
Taking Steps to Improve the Management
by mitsue-stanley
of Chronic HCV. This educational program and spea...
Updates in Treatment of Hepatitis C
Updates in Treatment of Hepatitis C
by cheryl-pisano
Gene LeSage, MD, FACP, AGAF. Objectives. HCV epid...
Updates in Treatment of Hepatitis C
Updates in Treatment of Hepatitis C
by myesha-ticknor
Gene LeSage, MD, FACP, AGAF. Objectives. HCV epid...
Description of Antivirals for Hepatitis C
Description of Antivirals for Hepatitis C
by conchita-marotz
LCDR Dwayne David, . PharmD. , BCPS, NCPS. Cherok...